NDAORALTABLET
Approved
Dec 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
9
Mechanism of Action
5-alpha Reductase Inhibitors
Pharmacologic Class:
5-alpha Reductase Inhibitor
Clinical Trials (5)
Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)
Started Aug 2013
1 enrolled
Benign Prostatic Hyperplasia
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
Started Oct 2010
917 enrolled
Androgenetic Alopecia
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
Started Sep 2010
696 enrolled
Benign Prostatic HyperplasiaEnlarged Prostate
The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy
Started Mar 2008
29 enrolled
HematuriaHematospermia
A Trial of PROSCAR (Finasteride) Versus Placebo in Men With an Initial Negative Prostate Biopsy
Started Feb 2008
19 enrolled
Enlarged Prostate